Pharmacology of ayahuasca administered in two repeated dosesDOS SANTOS, Rafael G; GRASA, Eva; VALLE, Marta et al.Psychopharmacologia. 2012, Vol 219, Num 4, pp 1039-1053, issn 0033-3158, 15 p.Article

The Inhalation toxicity of di-and triethanolamine upon repeated exposureGAMER, A. O; ROSSBACHER, R; KAUFMANN, W et al.Food and chemical toxicology. 2008, Vol 46, Num 6, pp 2173-2183, issn 0278-6915, 11 p.Article

Metrics to characterize concentration-time profiles in single- and multiple-dose bioequivalence studiesSTEINIJANS, V. W; SAUTER, R; HAUSCHKE, D et al.Drug information journal. 1995, Vol 29, Num 3, pp 981-987, issn 0092-8615Conference Paper

Hypnotic residual effects of benzodiazepines with repeated administrationROEHRS, T; KRIBBS, N; ZORICK, F et al.Sleep (New York, NY). 1986, Vol 9, Num 2, pp 309-316, issn 0161-8105Article

Pharmacokinetics of temafloxacin in humans after multiple oral dosesGRANNEMAN, G. R; CARPENTIER, P; MORRISON, P. J et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 2, pp 378-386, issn 0066-4804Article

Pharmacokinetics of loracarbef in pediatric patientsNAHATA, M. C; KORANYI, K. I.European journal of drug metabolism and pharmacokinetics. 1992, Vol 17, Num 3, pp 201-204, issn 0378-7966Article

Analysis of periodic injections in cancer chemotherapyLYBERATOS, G; ABULESZ, E.-M.International journal of systems science. 1990, Vol 21, Num 8, pp 1659-1671, issn 0020-7721Article

Loratadine: multiple-dose pharmacokineticsRADWANSKI, E; HILBERT, J; SYMCHOWICZ, S et al.Journal of clinical pharmacology. 1987, Vol 27, Num 7, pp 530-533, issn 0091-2700Article

Acute, Multiple-Dose Dermal and Genetic Toxicity of Nu-3: A Novel Antimicrobial AgentJUAN SUN; YANXIN HU; SHANPING CAO et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 362524.1-362524.8, 3Article

Patient Skin Dose during Neuroembolization by Multiple-Point Measurement Using a Radiosensitive IndicatorSUZUKI, S; FURUI, S; MATSUMARU, Y et al.American journal of neuroradiology. 2008, Vol 29, Num 6, pp 1076-1081, issn 0195-6108, 6 p.Article

Fixed drug eruption following rifampin treatmentMIMOUNI, A; HODAK, E; MIMOUNI, M et al.DICP (Cincinnati, Ohio). 1990, Vol 24, Num 10, pp 947-948, issn 1042-9611, 2 p.Article

Bioequivalence studies: single vs multiple doseSTEINIJANS, V. W; SAUTER, R; JONKMAN, J. H. G et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1989, Vol 27, Num 5, pp 261-266, issn 0174-4879Article

Residual plasma concentrations of acitretin (Ro-10-1670) and its metabolite (Ro-13-7652) after chronic administrationBERBIS, P; BUN, H; AL MALLAH, N. R et al.Dermatologica. 1988, Vol 177, Num 4, pp 244-246, issn 0011-9075Article

Drug absorption rate: a critical component of bioequivalence assessment in psychopharmacologyGREENBLATT, D. J; SHADER, R. I.Journal of clinical pharmacology. 1987, Vol 27, Num 2, pp 85-86, issn 0091-2700Article

The frequency of complications associated with the use of multiple-dose activated charcoalDORRINGTON, Catherine L; JOHNSON, David W; BRANT, Rollin et al.Annals of emergency medicine. 2003, Vol 41, Num 3, pp 370-377, issn 0196-0644, 8 p.Article

Assessment of drug accumulation in the evaluation of pharmacokinetic dataMEINEKE, I; GLEITER, C. H.Journal of clinical pharmacology. 1998, Vol 38, Num 8, pp 680-684, issn 0091-2700Article

Pharmacokinetic evaluation of pamidronate after oral administration : a study on dose proportionality, absolute bioavailability, and effect of repeated administrationHYLDSTRUP, L; FLESCH, G; HAUFFE, S. A et al.Calcified tissue international. 1993, Vol 53, Num 5, pp 297-300, issn 0171-967XArticle

Pharmacokinetics of trazodone during multiple dosing to psychiatric patientsNILSEN, O. G; DALE, O; HUSEBØ, B et al.Pharmacology & toxicology. 1993, Vol 72, Num 4-5, pp 286-289, issn 0901-9928Article

Pharmacokinetics of veralipride after chronic administration in humansSTAVERIS, S; PLUSQUELLEC, Y; CAMPISTRON, G et al.Journal of pharmaceutical sciences. 1988, Vol 77, Num 1, pp 64-67, issn 0022-3549Article

Predicting the time needed to achieve steady state if absorption and elimination constants are equalSINGER, J; VERECZKEY, L.Journal of pharmacokinetics and biopharmaceutics. 1999, Vol 27, Num 3, pp 297-300, issn 0090-466XArticle

Considerations in the attainment of steady state : Aggregate vs. individual assessmentHAUCK, W. W; TOZER, T. N; ANDERSON, S et al.Pharmaceutical research. 1998, Vol 15, Num 11, pp 1796-1798, issn 0724-8741Article

A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxantsFISHER, D. M; ROSEN, J. I.Anesthesiology (Philadelphia). 1986, Vol 65, Num 3, pp 286-291, issn 0003-3022Article

Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neuronsCHIODO, L. A; BUNNEY, B. S.The Journal of neuroscience. 1985, Vol 5, Num 9, pp 2539-2544, issn 0270-6474Article

Increased pressor effect of repeated doses of rat or porcine endothelin in the anaesthetised ratSPOKES, R. A; GHATEI, M. A; BLOOM, S. R et al.Life sciences (1973). 1990, Vol 47, Num 5, pp 433-437, issn 0024-3205, 5 p.Article

Residual effect of single and repeated doses of midazolam and nitrazepam in relation to their plasma concentrationsGODTLIBSEN, O. B; JERKØ, D; GORDELADZE, J. O et al.European journal of clinical pharmacology. 1986, Vol 29, Num 5, pp 595-600, issn 0031-6970Article